(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 12.6% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.17%.
Axogen's revenue in 2025 is $214,709,000.On average, 11 Wall Street analysts forecast AXGN's revenue for 2025 to be $10,504,351,320, with the lowest AXGN revenue forecast at $10,070,340,580, and the highest AXGN revenue forecast at $10,901,464,228.  On average, 11 Wall Street analysts forecast AXGN's revenue for 2026 to be $12,163,370,055, with the lowest AXGN revenue forecast at $11,345,160,648, and the highest AXGN revenue forecast at $12,785,098,511.  
In 2027, AXGN is forecast to generate $14,215,350,693 in revenue, with the lowest revenue forecast at $13,243,554,063 and the highest revenue forecast at $14,969,450,118.